Philip S Wells Selected Research

Postthrombotic Syndrome

12/2021	Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.
12/2021	Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.
2/2012	Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip S Wells Research Topics

Disease

75	Venous Thromboembolism 01/2022 - 07/2002
54	Hemorrhage 01/2022 - 07/2002
37	Pulmonary Embolism 01/2022 - 04/2003
25	Neoplasms (Cancer) 01/2022 - 01/2008
20	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 09/2002
18	Thrombosis (Thrombus) 12/2019 - 01/2003
6	Thrombophilia 02/2015 - 07/2003
5	Thromboembolism 01/2021 - 02/2006
4	Atrial Fibrillation 01/2021 - 01/2011
3	Postthrombotic Syndrome 12/2021 - 02/2012
2	Obesity 01/2021 - 01/2021
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021 - 12/2002
2	Stroke (Strokes) 01/2021 - 08/2012
2	Hyperpigmentation 01/2021 - 08/2008
2	Fibrosis (Cirrhosis) 01/2021 - 12/2006
2	Edema (Dropsy) 01/2021 - 08/2008
2	Right Ventricular Dysfunction 07/2020 - 09/2016
2	Body Weight (Weight, Body) 09/2016 - 09/2016
2	Thrombocytopenia (Thrombopenia) 11/2014 - 10/2005
2	Arteriovenous Fistula 09/2012 - 04/2005
2	Pathologic Constriction (Stenosis) 12/2006 - 09/2002
1	Critical Illness (Critically Ill) 01/2022
1	Chronic Renal Insufficiency 01/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021
1	Cerebral Hemorrhage 03/2017
1	Lung Diseases (Lung Disease) 02/2017
1	Heart Failure 02/2017
1	Liver Diseases (Liver Disease) 02/2017
1	Dyspnea (Shortness of Breath) 01/2017
1	Genetic Risk Score 01/2017
1	Iatrogenic Disease 11/2016
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2016
1	Uterine Hemorrhage (Uterine Bleeding) 03/2016
1	Pregnancy Complications 11/2014
1	Out-of-Hospital Cardiac Arrest 10/2014
1	Non-ST Elevated Myocardial Infarction 09/2012
1	Abdominal Aortic Aneurysm 08/2012
1	Vascular Diseases (Vascular Disease) 08/2012
1	Peripheral Arterial Disease 08/2012
1	Atherosclerosis 08/2012
1	Ischemic Stroke 08/2012

Drug/Important Bio-Agent (IBA)

46	AnticoagulantsIBA 01/2022 - 04/2003
25	RivaroxabanIBA 12/2018 - 10/2010
23	fibrin fragment D (D-dimer)IBA 01/2022 - 08/2003
20	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 05/2003
16	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 07/2002
12	apixabanIBA 01/2022 - 08/2013
10	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 07/2002
10	Vitamin K FDA Link 09/2016 - 04/2009
7	Pharmaceutical PreparationsIBA 01/2018 - 05/2005
6	edoxabanIBA 01/2018 - 09/2014
5	Dalteparin (Dalteparin Sodium)FDA Link 01/2021 - 04/2005
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 08/2013
5	factor V LeidenIBA 04/2017 - 12/2002
4	Enoxaparin (Lovenox)FDA LinkGeneric 09/2016 - 10/2010
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 02/2016
3	CreatinineIBA 01/2022 - 09/2016
3	Prothrombin (Factor II)IBA 04/2017 - 12/2009
3	Tinzaparin (Innohep)FDA Link 09/2012 - 04/2005
3	Factor XIII (Coagulation Factor XIII)IBA 04/2007 - 07/2006
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 08/2013
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 10/2018 - 12/2007
2	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 09/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017 - 09/2016
2	boldenone undecylenate (Equipoise)IBA 01/2017 - 07/2003
2	Dabigatran FDA Link 09/2014 - 08/2013
2	Fondaparinux (Arixtra)FDA Link 09/2014 - 02/2012
2	AntithrombinsIBA 05/2009 - 07/2003
2	Leucine (L-Leucine)FDA Link 10/2006 - 07/2006
1	Combined Oral ContraceptivesIBA 01/2021
1	Contraceptive Agents (Contraceptives)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 07/2020
1	HomocysteineIBA 01/2017
1	Clostridium perfringens epsilon-toxinIBA 01/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2016
1	Estrogens (Estrogen)FDA Link 03/2016
1	Hormones (Hormone)IBA 03/2016
1	4-chlorophenyl methyl sulfide (CPMS)IBA 12/2015
1	AcenocoumarolIBA 10/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Lipoprotein(a)IBA 08/2012

Therapy/Procedure

44	Therapeutics 01/2022 - 01/2003
10	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
6	Secondary Prevention 12/2021 - 04/2009
5	Length of Stay 01/2020 - 11/2016
3	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2018 - 10/2010
2	Vena Cava Filters (Inferior Vena Cava Filter) 12/2019 - 02/2010
2	Duration of Therapy 10/2013 - 04/2003
2	Orthopedic Procedures 01/2012 - 05/2009
2	Hip Replacement Arthroplasty (Total Hip Replacement) 11/2010 - 10/2010
2	Renal Dialysis (Hemodialysis) 12/2006 - 04/2005
1	Polypharmacy 01/2018
1	Prostheses and Implants (Prosthesis) 03/2017
1	Embolectomy 02/2017
1	Erythrocyte Transfusion 01/2017
1	Drug Tapering 09/2016
1	Blood Transfusion (Blood Transfusions) 02/2016
1	Induced Hypothermia 10/2014
1	Catheters 10/2014
1	Punctures 09/2012